MEDICLIN AG/ DE0006595101 /
| 2024-11-15 5:36:23 PM | Chg. 0.000 | Volume | Bid2024-11-15 | Ask2024-11-15 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.640EUR | 0.00% | 2,775 Turnover: 7,159.520 |
-Bid Size: - | -Ask Size: - | 118.75 mill.EUR | - | - |
Assets
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 150.3000 | 154.6000 | 161.6000 | 158.6000 | 155.5000 | ||||||
| Intangible Assets | 2.4000 | 1.9000 | 1.6000 | 1.6000 | 2 | ||||||
| Long-Term Investments | 1.5000 | 1.6000 | 1.6000 | 2.1000 | 1.5000 | ||||||
| Fixed Assets | 205.7000 | 212.5000 | 222.3000 | 221.1000 | 216.8000 | ||||||
| Inventories | 6.5000 | 6.8000 | 7.1000 | 6.5000 | 6.4000 | ||||||
| Accounts Receivable | 61.6000 | 58.1000 | 59.8000 | 61.4000 | 62 | ||||||
| Cash and Cash Equivalents | 48 | 41.3000 | 22.9000 | 13.2000 | 26.3000 | ||||||
| Current Assets | 125.6000 | 116.3000 | 97.3000 | 91.7000 | 102.8000 | ||||||
| Total Assets | 336.4000 | 328.8000 | 319.6000 | 312.9000 | 319.6000 | ||||||
Liabilities
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 15.2000 | 14.6000 | 17.3000 | 18.2000 | 13 | ||||||
| Long-term debt | 20.8000 | 22.7000 | 67 | 60.5000 | 54.1000 | ||||||
| Liabilities to Banks | 87.7000 | 90 | 75.9000 | 67.6000 | 61.2000 | ||||||
| Provisions | 43.9000 | 40.2000 | 48.1000 | 53.2000 | 64.5000 | ||||||
| Liabilities | 171.4000 | 163.2000 | 162.6000 | 160.7000 | 165.7000 | ||||||
| Share Capital | 47.5000 | 47.5000 | 47.5000 | 47.5000 | 47.5000 | ||||||
| Total Equity | 165 | 165.6000 | 157 | 152.2000 | 153.9000 | ||||||
| Minority Interests | .1000 | 0.0000 | -.1000 | -.2000 | -.4000 | ||||||
| Total liabilities equity | 336.4000 | 328.8000 | 319.6000 | 312.9000 | 319.6000 | ||||||
Income Statement
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 487.2000 | 493.6000 | 509.7000 | 515 | 538 | ||||||
| Depreciation (total) | 13.8000 | 16.7000 | 17.3000 | 17.5000 | 18.5000 | ||||||
| Operating Result | 16.9000 | 10.9000 | 4.3000 | 2.1000 | 15.6000 | ||||||
| Interest Income | -5.3000 | -5.1000 | -5 | -4.7000 | -3.8600 | ||||||
| Income Before Taxes | 11.6000 | 5.7000 | -.8000 | -2.6000 | 11.7000 | ||||||
| Income Taxes | 1.5000 | 2.8000 | .7000 | .2000 | 3.3000 | ||||||
| Minority Interests Profit | -.1000 | 0.0000 | .1000 | .1000 | .1000 | ||||||
| Net Income | 10 | 3 | -1.4000 | -2.6000 | 8.5000 | ||||||
Per Share
Cash Flow
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 13.4000 | 15.6000 | 16.2000 | 10 | 32.1000 | ||||||
| Cash Flow from Investing Activities | -16.1000 | -22.2000 | -20.4000 | -11.5000 | -12.5000 | ||||||
| Cash Flow from Financing | -7.9000 | 0.0000 | -14.2000 | -8.2000 | -6.5000 | ||||||
| Decrease / Increase in Cash | -10.6000 | -6.6000 | -18.4000 | -9.7000 | 13.1000 | ||||||
| Employees | 5,984 | 6,099 | 6,256 | 6,372 | 6,432 | ||||||
